Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.55 |
| ▸ | SHBG | P04278 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MLNR | O43193 | 1/20 | 0.41 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4653067 | 0.97 | EPHX1 (0.50) | EPHX1SHBGTP53LMNACYP2D6 | |
| SCHEMBL4654403 | 0.84 | — | — | |
| SCHEMBL9949234 | 0.78 | EPHX1 (0.50) | EPHX1SHBGTP53LMNACYP2D6 | |
| SCHEMBL9213980 | 0.77 | EPHX1 (0.42) | EPHX1SHBGTP53LMNACYP2D6 | |
| SCHEMBL9821330 | 0.75 | EPHX1 (0.60) | EPHX1SHBGTP53LMNACYP2D6 | |
| SCHEMBL3263270 | 0.74 | EPHX1 (0.40) | EPHX1SHBGTP53LMNACYP2D6 | |
| SCHEMBL3417081 | 0.74 | EPHX1 (0.46) | EPHX1SHBGTP53LMNACYP2D6 | |
| SCHEMBL9202551 | 0.73 | EPHX1 (0.38) | EPHX1SHBGTP53LMNAALDH1A1 | |
| SCHEMBL1193486 | 0.72 | SHBG (0.44) | EPHX1SHBGTP53LMNAMAPT | |
| SCHEMBL954759 | 0.72 | SHBG (0.44) | EPHX1SHBGTP53LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10328683-B2 | Adhesive agent, adhesive material using the same, and method of use thereof | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2019-06-25 | — | — | US | disclosed |
| US-10322572-B2 | Adhesive agent, adhesive material using the same, and method of use thereof | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2019-06-18 | — | — | US | disclosed |
| US-9446576-B2 | Adhesive agent, adhesive material using the same, and method of use thereof | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2016-09-20 | — | — | US | disclosed |
| CN-103391947-B | Stabilization of polymers containing hydrolyzable functional groups | 株式会社普利司通 | 2016-08-24 | — | — | CN | disclosed |
| US-20130020021-A1 | ADHESIVE AGENT, ADHESIVE MATERIAL USING THE SAME, AND METHOD OF USE THEREOF | HITACHI CHEMICAL COMPANY, LTD. | 2013-01-24 | — | — | US | disclosed |
| US-20130008592-A1 | ADHESIVE AGENT, ADHESIVE MATERIAL USING THE SAME, AND METHOD OF USE THEREOF | HITACHI CHEMICAL COMPANY, LTD. | 2013-01-10 | — | — | US | disclosed |
| US-20130008593-A1 | ADHESIVE AGENT, ADHESIVE MATERIAL USING THE SAME, AND METHOD OF USE THEREOF | HITACHI CHEMICAL COMPANY, LTD. | 2013-01-10 | — | — | US | disclosed |
| EP-2479159-A1 | PREPARATION METHOD FOR COMPOUND PROVIDED WITH DOUBLE BOND | Sumitomo Chemical Co., Ltd (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120165587-A1 | Method for Producing a Compound with a Double Bond | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-28 | — | — | US | disclosed |
| CN-102471176-A | Non-polar and polar leaving groups | BAYER SCHERING PHARMA AG | 2012-05-23 | — | — | CN | disclosed |
| EP-0846108-A1 | AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS | NEUROCRINE BIOSCIENCES, INC. (US) | 1998-06-10 | — | — | EP | disclosed |
| EP-0625507-B1 | Urea derivatives and their use as acat inhibitors | NISSHIN FLOUR MILLING CO (JP) | 1997-07-23 | — | — | EP | disclosed |
| US-5621010-A | ANTIHYPERCHOLESTEROLEMIA AND ANTIATHEROSCLEROSIS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1997-04-15 | — | — | US | disclosed |
| WO-1996039400-A1 | AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS | NEUROCRINE BIOSCIENCES, INC. (US) | 1996-12-12 | — | — | WO | disclosed |
| EP-0703505-A1 | Toner for two-component type developer | MITA INDUSTRIAL CO., LTD. (JP) | 1996-03-27 | — | — | EP | disclosed |
| EP-0625507-A2 | Urea derivatives and their use as acat inhibitors | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1994-11-23 | — | — | EP | disclosed |
| EP-0334845-B1 | LIQUID CRYSTAL COMPOUNDS, MIXTURES AND DEVICES | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1992-05-06 | — | — | EP | disclosed |
| US-5037576-A | Ferroelectric; increased polarization | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1991-08-06 | — | — | US | disclosed |
| WO-1988002390-A2 | LIQUID CRYSTAL COMPOUNDS, MIXTURES AND DEVICES | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNI (GB) | 1988-04-07 | — | — | WO | disclosed |
| CN-85104453-A | Prepare a kind of method that is used for the treatment of the tetrahydro naphthols of hypertension | — | 1986-12-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165587-A1 | Method for Producing a Compound with a Double Bond | ADH1C, ADH1A, ADH5 | EPHX1 1502/4885SHBG 1682/4885TP53 3750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.